Current Medicinal Chemistry-Cardiovascular & Hematological Agents

Title Publication Date Language Citations
Angiotensin-(1-7): Blood, Heart, and Blood Vessels2005/10/01English37
The Plasma and Tissue Kininogen-kallikrein-kinin System: Role in the Cardiovascular System2005/01/01English36
Blockers of the Kv1.5 Channel for the Treatment of Atrial Arrhythmias [1]2003/10/01English35
Natriuretic Peptide Family: New Aspects2005/04/01English34
New Insights into the Intracellular Mechanisms by Which PGI2 Analogues Elicit Vascular Relaxation: Cyclic AMP-Independent, Gs-Protein Mediated-Activation of MaxiK Channel2004/07/01English34
Capsaicin Sensitive-Sensory Nerves and Blood Pressure Regulation2003/06/01English30
Role of Calmodulin in Platelet Receptor Function2005/10/01English29
Cardiac Adrenomedullin: Its Role in Cardiac Hypertrophy and Heart Failure2005/07/01English29
Proteinase-Activated Receptor-2: Physiological and Pathophysiological Roles2003/03/01English28
Discovery of Potent Peptide-Mimetic Antagonists for the Human Thrombin Receptor, Protease-Activated Receptor-1 (PAR-1)2003/03/01English27
Discovery and Pre-clinical Development of Antithrombotics from Hematophagous Invertebrates2005/01/01English25
Anti-Inflammatory and Anti-Apoptotic Effects of Levosimendan in Decompensated Heart Failure: A Novel Mechanism of Drug-Induced Improvement in Contractile Performance of the Failing Heart2005/07/01English25
Snake Venom Metalloproteinase Containing a Disintegrin-like Domain, its Structure-activity Relationships at Interacting with Integrins2005/07/01English24
Angiotensin II Type I Receptor Blocker and Endothelial Function in Humans: Role of Nitric Oxide and Oxidative Stress2005/04/01English24
Thrombocytopenia in HIV Disease: Clinical Relevance, Physiopathology and Management2005/10/01English22
Physicochemical Determinants for Drug Induced Blockade of HERG Potassium Channels: Effect of Charge and Charge Shielding2003/10/01English21
New Advances in the Field of Calcium Channel Antagonists: Cardiovascular Effects and Structure-Activity Relationships2003/06/01English21
Fibrinolysis at the Fluid-Solid Interface of Thrombi2005/10/01English19
Dopamine Receptor and Hypertension2005/01/01English19
α2-Antiplasmin: Potential Therapeutic Roles in Fibrin Survival and Removal2004/10/01English18
The Multifunctional Protein C System2005/04/01English18
Structure-activity Relationships of Snake Toxins Targeting Platelet Receptors, Glycoprotein Ib-IX-V and Glycoprotein VI2003/06/01English18
Clinical Determination of the Severity of Metabolic Syndrome: Preheparin Lipoprotein Lipase Mass as a New Marker of Metabolic Syndrome2005/10/01English17
Understanding the Mechanism and Prevention of Arterial Occlusive Thrombus Formation by Anti-Platelet Agents2004/04/01English17
Vasoprotective Actions of the Atrial Natriuretic Peptide2005/01/01English17
Aspirin and Clopidogrel: A Sweeping Combination in Cardiology2005/07/01English17
Catalytic Features, Regulation and Function of Myocardial Phospholipase A22004/07/01English17
Diadenosine Polyphosphates: Postulated Mechanisms Mediating the Cardiac Effects2003/06/01English16
Recent Advances in Marine Algal Anticoagulants2004/01/01English16
Platelet Glycoprotein IIb / IIIa Inhibition and its Clinical Use2004/07/01English16